NP / PA
Burkett, Matthew
Burkett, Matthew was paid $108K by Medicaid between Feb 2022 and Jun 2023, across 35 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 49% of everything it billed.
33Billing provider infoBURKETT, MATTHEW
UNIONTOWN, PA 15401
UNIONTOWN, PA 15401
33aNPI1689654006assigned 01/20/2006
33bProvider typeFamily Nurse Practitioner
28Total paid$108K
24GClaims4,246
24DCodes billed35
24AFirst – last monthFeb 2022 – Jun 2023
Compared with peers
Next to other Family Nurse Practitioner providers in Pennsylvania
Rank by total paid#134 of 1,075
Median peer was paid$8K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 2,276 | $66K | |
| 2023 | 1,970 | $42K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 49% | 1,133 | 800 | $53K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 472 | 352 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.7% | 309 | 243 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.3% | 264 | 159 | $7K |
| 80053 | Comprehensive metabolic panel | 3.2% | 324 | 283 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 99 | 71 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.7% | 140 | 128 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.5% | 61 | 52 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 37 | 28 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 199 | 88 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 360 | 311 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 42 | 38 | $2K |
23 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 15 | $1K |
| 80061 | Lipid panel | <1% | 82 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 37 | $700.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $585.60 |
| 36000 | <1% | 82 | $497.84 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 83 | $469.70 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 17 | $315.57 |
| 81003 | <1% | 13 | $40.70 | |
| 3016F | 0% | 14 | $0.00 | |
| 1090F | 0% | 28 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 28 | $0.00 |
| 3288F | 0% | 15 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 29 | $0.00 |
| 3725F | 0% | 28 | $0.00 | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 0% | 38 | $0.00 |
| 1159F | 0% | 27 | $0.00 | |
| 1124F | 0% | 14 | $0.00 | |
| 1170F | 0% | 28 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 76 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 83 | $0.00 |
| 1101F | 0% | 15 | $0.00 | |
| 3044F | 0% | 24 | $0.00 | |
| 3008F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.